N.J. High Court Mulls Vioxx Class Status; $30B At Stake
In a decision that dramatically raises the stakes for Merck & Co., New Jersey's State Supreme Court has agreed to hear the drug maker's appeal of the class certification of a...To view the full article, register now.
Already a subscriber? Click here to view full article